GUO, LINXING – Trademark Portfolio

Entity Type: 01

GUO, LINXING holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 2 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include UBANT, ZHYOL, and RECITIM. The owner is based in SHENZHEN, GUANGDONG.

NO. 1, HUBIN ROAD, TANGGANG,

SHAJING STREET, BAOAN DISTRICT,

SHENZHEN, GUANGDONG , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RECITIM
RECITIM
Registered 2020
ZHYOL
ZHYOL
Registered 2020
UBANT
UBANT
Registered 2020

Trademark Classifications

GUO, LINXING's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

18
Leather Goods (2 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does GUO, LINXING have?

GUO, LINXING has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does GUO, LINXING file in?

GUO, LINXING files trademarks across 2 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 14 (Jewelry). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.

What are GUO, LINXING's most well-known trademarks?

GUO, LINXING's registered trademark portfolio includes well-known marks such as UBANT, ZHYOL, and RECITIM. These are among 3 currently registered trademarks in the portfolio.

What is GUO, LINXING's trademark registration success rate?

GUO, LINXING has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.